NEW YORK (GenomeWeb) – Leerink on Monday initiated coverage of molecular diagnostics firm Exact Sciences with an Outperform rating and a 12-month $30 price target on the company’s stock price.
Get the full story This story is free
for registered users
Registering provides access to this and other free content.
Already have an account?